About
Technology
Issues
FAQ
Links
Official Page
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.